A method for screening traditional Chinese medicine active ingredients based on anti-chemotherapy drug nephrotoxicity and drug interaction evaluation
By combining OCT2 cell membrane chromatography column with two-dimensional chromatography-mass spectrometry and in vivo pharmacodynamics verification, the problem of the disconnect between the screening and verification of active ingredients in traditional Chinese medicine has been solved. This method enables efficient and accurate screening and verification of components for the prevention and treatment of chemotherapy-induced nephrotoxicity, thereby improving the reliability and translational potential of the research results.
CN122449085APending Publication Date: 2026-07-24NORTHWEST UNIV
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CN202610704083.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-05-21
- Publication Date
- 2026-07-24
Smart Images

Figure CN122449085A_ABST
Abstract
The application belongs to the technical field of drug screening, analytical chemistry and pharmacology, and specifically discloses a method for screening traditional Chinese medicine active ingredients based on anti-chemotherapy drug nephrotoxicity and evaluating drug interactions. By constructing an OCT2 high-expression stable cell strain, using styrene-maleic anhydride copolymer to form OCT2 nanoliposomes, and covalently fixing the nanoliposomes on ethylene sulfone-based silica gel, an OCT2 cell membrane chromatographic column with high stability and high activity is prepared. Based on the OCT2 cell membrane chromatographic column, a two-dimensional biochromatographic method for specifically screening OCT2 binding components from traditional Chinese medicine extracts is established. With OCT2 as a specific target, the application combines high-bionic cell membrane chromatography technology, two-dimensional chromatography-mass spectrometry technology, in-vitro binding kinetics analysis, competitive drug interaction evaluation, computer simulation and in-vivo pharmacodynamic verification, and forms a complete research system from discovery to drug interaction evaluation and then to in-vivo confirmation.
Need to check novelty before this filing date? Find Prior Art
